Daphne Karydas - 13 Sep 2023 Form 3 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director
Signature
/s/ Adam Levy, Attorney-in-fact
Issuer symbol
MLYS
Transactions as of
13 Sep 2023
Net transactions value
$0
Form type
3
Filing time
14 Sep 2023, 16:14:11 UTC
Previous filing
17 Nov 2022
Next filing
20 Sep 2023

No securities are beneficially owned.

Remarks:

EXHIBIT LIST: EX-24 Daphne Karydas POA